Otsuka venture yanks sodium chloride for IV over labeling issue
An Otsuka joint venture is recalling one lot of sodium chloride for intravenous use over a labeling issue.
Otsuka Holdings
Otsuka is a small molecule pharma company covered in the openbionews harvest.
Company Info
Recent News
In a first, Otsuka's Voyxact stabilizes IgAN kidney loss in ph.3
Otsuka's Voyxact stabilized kidney function decline in IgAN patients in a Phase 3 trial, a first for the indication.
Otsuka’s ADHD approval opens up new drug class with $615M opportunity
Otsuka’s ADHD approval opens up new drug class with $615M opportunity.